關鍵數據
133.490今開
137.410最高
558.08K成交量
虧損本益比TTM
14.98本益比動
1.360股利TTM
1.26%換手率
132.300昨收
130.600最低
38.86M成交額
86.72本益比靜
1.93市淨率
0.99%股息率 TTM
0.02%ROA
139.67052週最高
1.23量比
69.67M淨利潤
44.20M總股本
-22.5552每股盈餘TTM
0.82Beta
0.04%ROE
100.18052週最低
5.15%振幅
56.07%毛利率
6.04B總市值
-0.75回報/風險
2.01%風險率
操作建議
Teleflex Inc當前公司基本面數據相對穩定,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名84/199位。機構持股佔比非常高,近一月多位分析師給出公司評級為持有。最高目標價為146.66。中期看,股價處於上升通道。近一個月,市場表現一般,但基本面評分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。
壓力支撐

由於公司未披露,未能獲取相關數據
Teleflex Inc新聞
即將為您帶來更多新聞,敬請期待。 。 。
收益預測
Zimmer Biomet Holdings Inc
ZBH
31
技術指標
財務指標
每股收益

由於公司未披露,未能獲取相關數據
營業總收入

由於公司未披露,未能獲取相關數據
Teleflex Inc簡介
Teleflex Incorporated is a global provider of medical technologies. The Company offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. It primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.
公司代碼TFX
公司Teleflex Inc
CEOKelly (Liam J)
網址https://www.teleflex.com/usa/en/#
公司股東
常見問題
Teleflex Inc(TFX)的當前股價是多少?
Teleflex Inc(TFX)的當前股價是 136.71。
Teleflex Inc股票的52週最高點是多少?
Teleflex Inc股票的52週最高點是139.67。
Teleflex Inc股票的52週最低點是多少?
Teleflex Inc股票的52週最低點是100.18。
現在Teleflex Inc(TFX)的股票是買入、持有還是賣出?
根據分析師評級,Teleflex Inc(TFX)的總體評級為signal_hold,目標價格為146.66。
Teleflex Inc(TFX)股票的每股收益(EPS TTM)是多少
Teleflex Inc(TFX)股票的每股收益(EPS TTM)是-20.30。